Nuveen Asset Management, LLC Replimune Group, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 319,641 shares of REPL stock, worth $4.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

319,641

Previous 231,967 37.8%

Holding current value

$4.09 Million

Previous $2.09 Million 67.85%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$8.09 - $11.23 $709,282 - $984,579	87,674 Added 37.8%	319,641 $3.5 Million
Q2 2024 Aug 09, 2024	BUY	$5.01 - $9.46 $576,049 - $1.09 Million	114,980 Added 98.28%	231,967 $2.09 Million
Q4 2023 Feb 14, 2024	BUY	$6.75 - $16.18 $86,103 - $206,392	12,756 Added 12.24%	116,987 $986,000
Q3 2023 Nov 14, 2023	SELL	$15.96 - $22.18 $1.43 Million - $1.99 Million	-89,833 Reduced 46.29%	104,231 $1.78 Million
Q2 2023 Aug 14, 2023	BUY	$15.65 - $24.1 $59,000 - $90,857	3,770 Added 1.98%	194,064 $4.51 Million
Q1 2023 May 15, 2023	SELL	$17.48 - $29.09 $129,841 - $216,080	-7,428 Reduced 3.76%	190,294 $3.36 Million
Q4 2022 Feb 14, 2023	BUY	$17.09 - $27.91 $1.05 Million - $1.71 Million	61,447 Added 45.09%	197,722 $5.38 Million
Q3 2022 Nov 14, 2022	SELL	$15.6 - $21.15 $119,948 - $162,622	-7,689 Reduced 5.34%	136,275 $2.35 Million
Q2 2022 Aug 15, 2022	BUY	$13.32 - $19.98 $432,167 - $648,251	32,445 Added 29.09%	143,964 $2.52 Million
Q1 2022 May 16, 2022	BUY	$15.24 - $29.75 $389,671 - $760,677	25,569 Added 29.75%	111,519 $1.76 Million
Q4 2021 Feb 14, 2022	SELL	$25.43 - $34.25 $179,128 - $241,257	-7,044 Reduced 7.57%	85,950 $2.26 Million
Q3 2021 Nov 12, 2021	SELL	$28.98 - $39.54 $448,842 - $612,395	-15,488 Reduced 14.28%	92,994 $3.03 Million
Q2 2021 Aug 16, 2021	BUY	$28.5 - $39.37 $5,187 - $7,165	182 Added 0.17%	108,482 $4.17 Million
Q1 2021 May 17, 2021	SELL	$30.22 - $45.57 $487,176 - $734,633	-16,121 Reduced 12.96%	108,300 $3.3 Million
Q4 2020 Feb 16, 2021	SELL	$23.5 - $52.65 $3.02 Million - $6.77 Million	-128,529 Reduced 50.81%	124,421 $4.75 Million
Q3 2020 Nov 16, 2020	BUY	$18.85 - $27.0 $877,618 - $1.26 Million	46,558 Added 22.56%	252,950 $5.82 Million
Q2 2020 Aug 14, 2020	BUY	$9.76 - $25.95 $398,900 - $1.06 Million	40,871 Added 24.69%	206,392 $5.13 Million
Q1 2020 May 14, 2020	BUY	$8.9 - $19.08 $1.07 Million - $2.3 Million	120,425 Added 267.04%	165,521 $1.65 Million
Q4 2019 Feb 14, 2020	BUY	$11.61 - $17.21 $177,679 - $263,381	15,304 Added 51.37%	45,096 $647,000
Q3 2019 Nov 14, 2019	BUY	$10.01 - $16.87 $21,101 - $35,561	2,108 Added 7.61%	29,792 $414,000
Q2 2019 Aug 15, 2019	BUY	$12.51 - $17.28 $346,326 - $478,379	27,684 New	27,684 $406,000

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $631M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Replimune Group, Inc. Transaction History